NEW YORK (AP) – Meet the generation of investors who haven’t known a bear market. The U.S. stock market has been on the upswing for nine and a half years, during which a cohort of younger investors has never dealt with a 20 percent drop in the S&P 500 – the classic definition of a bear market. Such a decline historically has happened on average every four or five years. That’s nice for these 20- and 30-somethings, and their retirement accounts, but it raises the question: What will they do when the next downturn inevitably arrives? How they respond will be crucial because this generation bears a heavier responsibility for paying for their own retirement, as pensions go extinct and Social Security’s finances weaken. Few analysts are predicting an imminent downturn for the S&P 500, which finished Tuesday within 0.8 percent of its record, but they’re much less confident about 2019 or beyond due to rising interest rates and other market … [Read more...] about Bull market is all many young investors know: What will they do when a downturn inevitably arrives?
T rowe price investor relations
/EIN News/ -- Dublin, June 08, 2018 (GLOBE NEWSWIRE) -- The "T-Cell Immunotherapy Market (3rd Edition), 2018-2030" report has been added to ResearchAndMarkets.com's offering. The "T-Cell Immunotherapy Market, 2018-2030 (3rd edition)" report features an extensive study of the current market landscape and the future potential of T-cell immunotherapies (focusing particularly on CAR-T therapies, TCR therapies and TIL therapies). One of the key objectives of the study was to review and quantify the future opportunities associated with the ongoing development programs of both small and big pharmaceutical firms. Cancer is known to be one of the leading causes of death worldwide, accounting for 0.6 million deaths in 2017 in the US alone. The World Health Organization states that the number of new cancer cases globally is expected to rise by 70% in the coming 20 years. Although cancer therapeutics continue to be one of the most active areas in terms of drug development, … [Read more...] about T-Cell Immunotherapy Market, 2030
/EIN News/ -- Dublin, May 16, 2018 (GLOBE NEWSWIRE) -- The "Gene Therapy Market (2nd Edition), 2018-2030" report has been added to ResearchAndMarkets.com's offering. The Gene Therapy Market (2nd Edition), 2018-2030' report provides an extensive study on the current market landscape of gene therapies, with a prime focus on gene augmentation based therapies and oncolytic viral therapies, featuring an elaborate discussion on the future potential of this evolving market. The year 2017 was particularly eventful; despite the withdrawal of Glybera from the European market in early 2017, the latter half of the year witnessed the approval of two gene therapies, namely Invossa and Luxturna. In fact, Luxturna became the first gene therapy to gain approval in the US. Further, promising clinical results were reported for several gene therapies that are currently in late phases of development. The growing popularity and potential of gene therapies can be correlated with an … [Read more...] about Gene Therapy Market, 2030
By Ryan Dube and Ryan Dube The Wall Street Journal BiographyRyan Dube [email protected] Alberto Messer Updated May 9, 2018 7:41 p.m. ET 3 COMMENTS BUENOS AIRES—Argentine President Mauricio Macri’s decision to turn to the International Monetary Fund has likely bought the country some time to stabilize a growing financial crisis. But the move also comes with a large political cost for Mr. Macri by tying the economy to an institution that is widely disliked here. Argentine stock prices rose 4% on Wednesday, a welcome relief rally for investors who have watched the country’s stocks, currency and bonds dive since the end of April, though the dollar was up 1.4% against the peso in Wednesday afternoon trading and has tumbled some 12% since late April. Despite hints of a respite from market turmoil, the turn to the IMF will spook ordinary Argentines, and signals the government will speed up unpopular austerity measures to get the country’s finances in … [Read more...] about Seeking IMF Aid Brings Argentina Relief—And Political Challenges
Share Tweet Share Email Comments Print Technology companies and banks helped power U.S. stocks to solid gains Wednesday, improving on the market’s flat finish a day earlier. Energy stocks led the gainers after the price of crude oil climbed back above $70 a barrel a day after the U.S. moved to withdraw from a nuclear accord with Iran. Gains in industrial and materials companies outweighed losses in safe-play sectors such as utilities and phone companies. “The areas of strength that you’re seeing today are encouraging,” said Willie Delwiche, investment strategist at Baird. “Energy, financials, materials and industrials. Those are more cyclical areas of the market, and that speaks to economic strength and a risk appetite on the part of investors.” Enlarge RELATED: Searchable stock index The S&P 500 index rose 25.87 points, or 1 percent, to 2,697.79. The gain nudged the benchmark index into positive territory for the … [Read more...] about U.S. stock indexes deliver solid gains as oil prices surge